Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 71.84M | 74.35M | 78.93M | 83.89M | 82.23M | 69.52M |
Gross Profit | 37.76M | 39.15M | 42.31M | 46.24M | 44.05M | 36.76M |
EBITDA | 1.86M | 6.15M | 10.52M | 15.91M | 19.19M | 7.11M |
Net Income | -7.65M | -11.51M | -6.84M | 2.40M | 8.16M | -4.93M |
Balance Sheet | ||||||
Total Assets | 31.19M | 31.25M | 49.60M | 54.35M | 53.97M | 35.61M |
Cash, Cash Equivalents and Short-Term Investments | 12.09M | 5.89M | 9.94M | 13.86M | 17.56M | 7.75M |
Total Debt | 10.48M | 14.29M | 21.60M | 20.35M | 11.84M | 11.52M |
Total Liabilities | 19.24M | 22.56M | 29.40M | 27.30M | 29.32M | 19.12M |
Stockholders Equity | 11.95M | 8.69M | 20.20M | 27.05M | 24.65M | 16.49M |
Cash Flow | ||||||
Free Cash Flow | 13.94M | 13.52M | 12.49M | 11.14M | 21.69M | 11.85M |
Operating Cash Flow | 13.94M | 13.57M | 13.10M | 11.70M | 21.72M | 11.87M |
Investing Cash Flow | -6.00K | -46.00K | -615.00K | -557.00K | -31.00K | -22.00K |
Financing Cash Flow | -16.96M | -17.57M | -16.41M | -14.84M | -11.88M | -11.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $252.73B | 15.06 | 28.11% | 2.60% | 11.51% | 47.88% | |
79 Outperform | HK$1.04T | 7.27 | 7.12% | 11.71% | 37.04% | ||
76 Outperform | $90.39B | 19.66 | 13.20% | 2.54% | -9.60% | -27.18% | |
65 Neutral | HK$77.77B | 26.46 | 11.45% | 0.75% | 18.80% | 142.93% | |
56 Neutral | HK$24.88B | 3.87 | -2.03% | 6.54% | -0.32% | -67.68% | |
41 Neutral | HK$18.49M | ― | -73.41% | ― | -4.84% | 20.93% | |
40 Neutral | $1.80B | ― | ― | -4.77% | -15.54% |